Lean Mass Gain Protocol

Overview

Lean mass gain requires three aligned inputs: progressive mechanical tension via resistance training, a modest caloric surplus with adequate protein, and hormonal conditions supportive of anabolism. Peptides in this category primarily support the third leg — particularly the GH/IGF-1 axis — while training and nutrition remain the dominant drivers.

This protocol differs from the more generalist Muscle Building Protocol by incorporating MGF (mechano growth factor) as a local anabolic signal and using a carefully timed Ipamorelin + CJC-1295 pairing to amplify endogenous GH pulses without chronic exogenous GH administration.

Compounds Involved

Ipamorelin + CJC-1295 (no-DAC)

The pairing of Ipamorelin with CJC-1295 (without DAC) produces a pulsatile GH release pattern that more closely resembles endogenous secretion than the continuous elevation of CJC-1295 with DAC. This pulsatile pattern is generally preferred for physiologic tolerance and receptor sensitivity.

MGF

Mechano growth factor is a splice variant of IGF-1 expressed in response to mechanical load. Exogenous MGF (often as PEG-MGF for extended half-life) is used post-workout to amplify satellite cell activation in the trained tissue.

Protocol Structure

Phase 1 — Foundation (Weeks 1–4)

Before adding peptides, validate that training and nutrition are actually sufficient. A common mistake is stacking peptides onto an inadequate training stimulus or caloric intake.

• Training — 4–5 sessions/week, compound-focused, progressive overload tracked
• Nutrition — 250–500 kcal surplus, 1.8–2.2 g/kg protein, 4–6 g/kg carbohydrates on training days
• Sleep — 8+ hours, consistent schedule
• Creatine 5 g/day, continuous

Phase 2 — GH Axis Support (Weeks 5–16)

Dosing schedule:

• Morning (upon waking, fasted):
  • Ipamorelin 200 mcg + CJC-1295 (no-DAC) 100 mcg subcutaneous
• Pre-workout (30–60 min before training, if mid-day training):
  • Ipamorelin 200 mcg + CJC-1295 100 mcg
• Pre-bed (2+ hours after last meal):
  • Ipamorelin 300 mcg + CJC-1295 100 mcg

All injections subcutaneous in abdomen or thigh, insulin syringe.

Phase 3 — Local Anabolic Layer (Targeted Weeks)

• MGF 200 mcg intramuscular to a trained muscle group, immediately post-workout, 2–3 sessions/week
• Rotate injection sites weekly to match training split
• Layer for 4–6 weeks during a targeted hypertrophy block

Phase 4 — Deload and Cycling

• Every 8–12 weeks, run a 1-week deload in training and a 2–4 week full peptide off-cycle
• Re-enter with baseline measurements (bodyweight, bodyfat, strength numbers, DEXA if available)

Duration

Total on-cycle: typically 12–16 weeks. Off-cycle: 4 weeks minimum. GH secretagogue use is generally well tolerated for long cycles but receptor desensitization and water retention tend to increase with duration.

Important Considerations

• GH secretagogues are not anabolic steroids and do not produce anywhere near the hypertrophy of exogenous testosterone. Expectations should be calibrated accordingly.
• Water retention, mild carpal tunnel symptoms, and joint stiffness are common with any GH-axis intervention. Symptoms generally resolve with dose reduction.
• Insulin sensitivity can decline modestly with elevated GH. Monitor fasting glucose and HbA1c during longer cycles.
• IGF-1 elevation theoretically affects cancer risk; any personal or family history of proliferative malignancy is a reason to avoid these tools.
• MGF is an IGF-1 analog and theoretically carries the same cautions around malignancy.
• All peptides discussed are WADA-prohibited. Tested athletes should not use this protocol (see Pre-Competition Protocol).
• Ensure sterile injection technique. Peptides are reconstituted in bacteriostatic water and stored refrigerated.
• Women can use GH secretagogues at roughly 50–70% of male dosing with similar safety profile.

Disclaimer

This content is for educational and informational purposes only and is not medical advice. Ipamorelin, CJC-1295, and MGF are not FDA-approved for human use in the United States and are sold as research chemicals in most jurisdictions. These compounds are prohibited by WADA and most anti-doping bodies. Consult a qualified clinician before beginning any peptide protocol, particularly if you have endocrine, metabolic, or oncologic conditions. Pepperpedia does not endorse the acquisition or use of unapproved substances.